Cote d'Ivoire Pharmaceuticals and Healthcare Report Q3 2013
5/15/2013 | published by: Business Monitor International
... are many challenges to doing business inthe country, not least the presence of substandard drugs, lack of trained healthcare personnel, weak IPframework and supply chain concerns (such as a lack of suitable storage facilities in ...
|
read more...
|
$1,295.00
|
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q3 2013
5/15/2013 | published by: Business Monitor International
... a downside risk to the future growthpotential of the pharmaceutical industry. Headline Expenditure Projections Pharmaceuticals: SDG1.92bn (US$540mn) in 2012 to SDG2.38bn (US$510mn) in 2013; +24.0% inlocal currency terms with a contraction of -6.8% in US ...
|
read more...
|
$1,295.00
|
Japan Pharmaceuticals and Healthcare Report Q3 2013
5/15/2013 | published by: Business Monitor International
... looking to expand in the country. Meanwhile, domestic firms willcontinue to expand overseas (especially in emerging markets) in order to maintain revenue growth. Headline Expenditure Projections Pharmaceuticals: JPY10,358bn (US$129.7) in 2012 to JPY10,823bn (US$118.9bn) in ...
|
read more...
|
$1,295.00
|
Pakistan Pharmaceuticals and Healthcare Report Q3 2013
5/15/2013 | published by: Business Monitor International
... burden over the next two decades -continuing to limit revenue earning opportunities for companies whose product portfolios containmedicines for the treatment of long-term diseases. Headline Expenditure Projections Pharmaceuticals: PKR189.21bn (US$2.03bn) in 2012 to PRK209.65bn (US2.11bn) ...
|
read more...
|
$1,295.00
|
Healthcare Building Construction in China to 2016: Market Databook
5/13/2013 | published by: Timetric
... including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the construction output and value-add methods. Summary ...
|
read more...
|
$500.00
|
Russian Pharma Industry In Details
5/9/2013 | published by: Euroresearch & Consulting
... The report is ready to be used for presentations, research reports and strategies. The report could also be used in preparation of marketing materials. The focus of the report – development of pharma market in ...
|
read more...
|
$3,750.00
|
Switzerland Pharmaceuticals and Healthcare Report Q2 2013
5/8/2013 | published by: Business Monitor International
... believes the government needs to do more to alter patients' attitudestowards these drugs as this is the main growth deterrent. Headline Expenditure Projections Pharmaceuticals: CHF6.58bn (US$7.02bn) in 2012 to CHF6.44bn (US$6.27bn) in 2013; -2.1% declinein ...
|
read more...
|
$1,175.00
|
Australia Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
... will stand tobenefit from the patented to generic drug switch. However, given that generic costs is higher in Australia ascompared to other developed countries, a downside risk to the view is the lack of generic ...
|
read more...
|
$1,175.00
|
Cameroon Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
... we project that the fullpotential of the pharmaceutical sector will only be seen if major improvements are made to Cameroon'seconomy and government contributions to healthcare. Headline Expenditure Projections Pharmaceuticals: XAF134.81bn (US$260mn) in 2012 to XAF153.17bn ...
|
read more...
|
$1,175.00
|
Namibia Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
... (US$268mn) in 2012 to NAD2.36bn (US$259mn) in 2013; +7.1% inlocal currency and -3.3% in US dollar terms. Healthcare: NAD5.08bn (US$619mn) in 2012 to NAD5.40bn (US$594mn) in 2013; +6.3% in localcurrency and -4.0% in US dollar ...
|
read more...
|
$1,175.00
|
Nigeria Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
... should be considered by the government asa means of reducing import reliance. Evidently, it would lead to shortages in medicine supplies. However,in light of evidence that fixed capital investments may have been increasing over the ...
|
read more...
|
$1,175.00
|
Angola Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
... growing middle class and demand for healthcare is climbing. However there areconsiderable gaps between the needs of the affluent, urban population, and those living in isolated, ruralparts of the country. The burden of disease also ...
|
read more...
|
$1,175.00
|
Gabon Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
... significant health burden over the next twodecades. This will continue to limit revenue-earning opportunities for companies whose product portfolioscontain treatments for long-term diseases. Headline Expenditure Forecasts Pharmaceuticals: XAF67.65bn (US$136mn) in 2012 to XAF72.45bn (US$148mn) in ...
|
read more...
|
$1,175.00
|
Mexico Pharmaceuticals and Healthcare Report Q3 2013
5/8/2013 | published by: Business Monitor International
... will grow ata rate of 8.8% in 2013 in local currency terms and 14.4% in US dollar terms. Headline Expenditure Projections Pharmaceuticals: MXN176.00bn (US$13.38bn) in 2012 to MXN191.42bn (US$15.31bn) in 2013;+8.8% in local currency terms ...
|
read more...
|
$1,175.00
|
Pharmacy Retail Market in India 2013
5/8/2013 | published by: Netscribes (India) Pvt. Ltd.
... projected towards significant growth due to the already existing varied disease profile as well as the emerging new diseases and the growing population size being affected by such diseases. The pharmacy sector forms the second ...
|
read more...
|
$850.00
|
Detroit Medical Center - Strategic SWOT Analysis Review
5/7/2013 | published by: GlobalData
... and surgical emergencies traumatic brain surgery services and emergency psychiatry. It also provides women’s services, organ transplant, cardiology, stroke treatment, optometry, orthopedics, obstetrics/gynecology, gerontology, bariatric surgery services and rehabilitation. DMC carries out research programs which ...
|
read more...
|
$125.00
|
Home Health Care Services
5/6/2013 | published by: First Research, Inc.
... their homes. Major companies include AMEDYSIS, Apria Healthcare Group, Gentiva Health Services, and Lincare Holdings (all based in the US), along with LVL Médical Groupe (France), and Nestor Healthcare Group (UK). Expenditures on home health ...
|
read more...
|
$129.00
|
Nursing Homes & Long-Term Care Facilities
5/6/2013 | published by: First Research, Inc.
... Senior Living, Kindred Healthcare, Golden Horizons (owned by GGNSC Holdings), and SunBridge Healthcare (subsidiary of Sun Healthcare Group). Internationally, demand for nursing homes and assisted living services is growing along with the aging population. While ...
|
read more...
|
$129.00
|
Outpatient Surgical Centers
5/6/2013 | published by: First Research, Inc.
... do not offer overnight or long-term hospital care. Major US companies include AmSurg, Symbion, and United Surgical Partners International, as well as the outpatient surgical operations of major hospital chains such as Tenet Health Care ...
|
read more...
|
$129.00
|
Business Strategy: Accountable Care Maturity Model
5/6/2013 | published by: IDC
... healthcare executives the ability to establish a benchmark for their organizations and to understand future requirements to determine their organization's road map. The maturity model gives healthcare executives the ability to understand requirements across all ...
|
read more...
|
$4,500.00
|
Aurora Health Care, Inc. - Strategic SWOT Analysis Review
5/3/2013 | published by: GlobalData
... services, primary care, women's health care and others. These services are offered through a wide range of primary and specialty physicians, diagnostic services and wellness programs. AHC also offers home care services such as nursing, ...
|
read more...
|
$125.00
|
|
|
$1,020.00
|
Booming Medical Tourism in Malaysia
5/1/2013 | published by: RNCOS
... field of medical treatment. Healthcare expense in developed countries together with the issue of time is making people seek affordable healthcare services in developing countries such as Malaysia. In their latest research study, “ Booming ...
|
read more...
|
$800.00
|
Chile Pharmaceuticals and Healthcare Report Q2 2013
5/1/2013 | published by: Business Monitor International
... market. It will also help to bring local drugmakers upto international standards, and in the long term, improve their competitiveness in the domestic and regionalmarkets. Foreign drugmakers with products which have been held to tougher ...
|
read more...
|
$1,175.00
|
Central America Pharmaceuticals and Healthcare Report Q3 2013
5/1/2013 | published by: Business Monitor International
... the region provides revenuegeneratingopportunities for generic drugmakers from neighbouring Latin American countries and India. We believe that Costa Rica will continue to attract investment as a regional pharmaceutical production hub. We also highlight that Panama ...
|
read more...
|
$1,175.00
|